FUNGINIX JOCK ITCH TREATMENT

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: FUNGINIX JOCK ITCH TREATMENT
Generic name: TOLNAFTATE
Manufacturer: The Sisquoc Healthcare Corporation
Product type: HUMAN OTC DRUG
SPL set ID: b2ce1c25-93d5-441f-9b3b-68ae46400c2c
SPL ID: 2f0087ac-d89a-ebe7-e063-6294a90ad9e8
Version: 6
Effective date: 2025-02-25
Source export date: 2026-09-28
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:14:28

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		FUNGINIX JOCK ITCH TREATMENT	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		The Sisquoc Healthcare Corporation	openfda.manufacturer_name
ndc	package	71229-104-11	openfda.package_ndc
ndc	product	71229-104	openfda.product_ndc
ndc11	package	71229010411	derived:openfda.package_ndc
rxcui		103951	openfda.rxcui
spl id		2f0087ac-d89a-ebe7-e063-6294a90ad9e8	id
spl set id		b2ce1c25-93d5-441f-9b3b-68ae46400c2c	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS FOR EXTERNAL USE ONLY. DO NOT USE ON CHILDREN UNDER 2 YEARS OF AGE UNLESS DIRECTED BY A DOCTOR. WHEN USING THIS PRODUCT AVOID CONTACT WITH THE EYES. IF CONTACT OCCURS, RINSE THE EYES VERY THOROUGHLY WITH WATER. STOP USE AND ASK A DOCTOR IF IRRITATION OCCURS OR THERE IS NO IMPROVEMENT WITHIN 4 WEEKS.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.